Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials

CRISP Investigators

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

The rate of renal disease progression varies widely among patients with autosomal dominant polycystic kidney disease (ADPKD), necessitating optimal patient selection for enrollment into clinical trials. Patients from the Mayo Clinic Translational PKD Center with ADPKD (n=590) with computed tomography/magnetic resonance images and three or more eGFR measurements over ≥6 months were classified radiologically as typical (n=538) or atypical (n=52). Total kidney volume (TKV) was measured using stereology (TKVs) and ellipsoid equation (TKVe). Typical patients were randomly partitioned into development and internal validation sets and subclassified according to height-adjusted TKV (HtTKV) ranges for age (1A-1E, in increasing order). Consortium for Radiologic Imaging Study of PKD (CRISP) participants (n=173) were used for external validation. TKVe correlated strongly with TKVs, without systematic underestimation or overestimation. A longitudinal mixed regression model to predict eGFR decline showed that log2HtTKV and age significantly interacted with time in typical patients, but not in atypical patients. When 1A-1E classifications were used instead of log2HtTKV, eGFR slopes were significantly different among subclasses and, except for 1A, different from those in healthy kidney donors. The equation derived from the development set predicted eGFR in both validation sets. The frequency of ESRD at 10 years increased from subclass 1A(2.4%) to 1E (66.9%) in the Mayo cohort and from 1C (2.2%) to 1E (22.3%) in the younger CRISP cohort. Class and subclass designations were stable. An easily applied classification of ADPKD based on HtTKV and age should optimize patient selection for enrollment into clinical trials and for treatment when one becomes available.

Original languageEnglish (US)
Pages (from-to)160-172
Number of pages13
JournalJournal of the American Society of Nephrology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Autosomal Dominant Polycystic Kidney
Clinical Trials
Kidney
Patient Selection
Chronic Kidney Failure
Disease Progression
Cohort Studies
Magnetic Resonance Spectroscopy
Tomography
Tissue Donors

ASJC Scopus subject areas

  • Nephrology

Cite this

Imaging classification of autosomal dominant polycystic kidney disease : A simple model for selecting patients for clinical trials. / CRISP Investigators.

In: Journal of the American Society of Nephrology, Vol. 26, No. 1, 01.01.2015, p. 160-172.

Research output: Contribution to journalArticle

@article{fca7d488a939469db8b041014ce2d322,
title = "Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials",
abstract = "The rate of renal disease progression varies widely among patients with autosomal dominant polycystic kidney disease (ADPKD), necessitating optimal patient selection for enrollment into clinical trials. Patients from the Mayo Clinic Translational PKD Center with ADPKD (n=590) with computed tomography/magnetic resonance images and three or more eGFR measurements over ≥6 months were classified radiologically as typical (n=538) or atypical (n=52). Total kidney volume (TKV) was measured using stereology (TKVs) and ellipsoid equation (TKVe). Typical patients were randomly partitioned into development and internal validation sets and subclassified according to height-adjusted TKV (HtTKV) ranges for age (1A-1E, in increasing order). Consortium for Radiologic Imaging Study of PKD (CRISP) participants (n=173) were used for external validation. TKVe correlated strongly with TKVs, without systematic underestimation or overestimation. A longitudinal mixed regression model to predict eGFR decline showed that log2HtTKV and age significantly interacted with time in typical patients, but not in atypical patients. When 1A-1E classifications were used instead of log2HtTKV, eGFR slopes were significantly different among subclasses and, except for 1A, different from those in healthy kidney donors. The equation derived from the development set predicted eGFR in both validation sets. The frequency of ESRD at 10 years increased from subclass 1A(2.4{\%}) to 1E (66.9{\%}) in the Mayo cohort and from 1C (2.2{\%}) to 1E (22.3{\%}) in the younger CRISP cohort. Class and subclass designations were stable. An easily applied classification of ADPKD based on HtTKV and age should optimize patient selection for enrollment into clinical trials and for treatment when one becomes available.",
author = "{CRISP Investigators} and {Irazabal Mira}, Maria and Rangel, {Laureano J.} and Bergstralh, {Eric J.} and Osborn, {Sara L.} and Harmon, {Amber J.} and Sundsbak, {Jamie L.} and Bae, {Kyongtae T.} and Chapman, {Arlene B.} and Grantham, {Jared J.} and Michal Mrug and Hogan, {Marie C} and El-Zoghby, {Ziad M} and Harris, {Peter C} and Erickson, {Bradley J} and King, {Bernard Francis} and Vicente Torres",
year = "2015",
month = "1",
day = "1",
doi = "10.1681/ASN.2013101138",
language = "English (US)",
volume = "26",
pages = "160--172",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Imaging classification of autosomal dominant polycystic kidney disease

T2 - A simple model for selecting patients for clinical trials

AU - CRISP Investigators

AU - Irazabal Mira, Maria

AU - Rangel, Laureano J.

AU - Bergstralh, Eric J.

AU - Osborn, Sara L.

AU - Harmon, Amber J.

AU - Sundsbak, Jamie L.

AU - Bae, Kyongtae T.

AU - Chapman, Arlene B.

AU - Grantham, Jared J.

AU - Mrug, Michal

AU - Hogan, Marie C

AU - El-Zoghby, Ziad M

AU - Harris, Peter C

AU - Erickson, Bradley J

AU - King, Bernard Francis

AU - Torres, Vicente

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The rate of renal disease progression varies widely among patients with autosomal dominant polycystic kidney disease (ADPKD), necessitating optimal patient selection for enrollment into clinical trials. Patients from the Mayo Clinic Translational PKD Center with ADPKD (n=590) with computed tomography/magnetic resonance images and three or more eGFR measurements over ≥6 months were classified radiologically as typical (n=538) or atypical (n=52). Total kidney volume (TKV) was measured using stereology (TKVs) and ellipsoid equation (TKVe). Typical patients were randomly partitioned into development and internal validation sets and subclassified according to height-adjusted TKV (HtTKV) ranges for age (1A-1E, in increasing order). Consortium for Radiologic Imaging Study of PKD (CRISP) participants (n=173) were used for external validation. TKVe correlated strongly with TKVs, without systematic underestimation or overestimation. A longitudinal mixed regression model to predict eGFR decline showed that log2HtTKV and age significantly interacted with time in typical patients, but not in atypical patients. When 1A-1E classifications were used instead of log2HtTKV, eGFR slopes were significantly different among subclasses and, except for 1A, different from those in healthy kidney donors. The equation derived from the development set predicted eGFR in both validation sets. The frequency of ESRD at 10 years increased from subclass 1A(2.4%) to 1E (66.9%) in the Mayo cohort and from 1C (2.2%) to 1E (22.3%) in the younger CRISP cohort. Class and subclass designations were stable. An easily applied classification of ADPKD based on HtTKV and age should optimize patient selection for enrollment into clinical trials and for treatment when one becomes available.

AB - The rate of renal disease progression varies widely among patients with autosomal dominant polycystic kidney disease (ADPKD), necessitating optimal patient selection for enrollment into clinical trials. Patients from the Mayo Clinic Translational PKD Center with ADPKD (n=590) with computed tomography/magnetic resonance images and three or more eGFR measurements over ≥6 months were classified radiologically as typical (n=538) or atypical (n=52). Total kidney volume (TKV) was measured using stereology (TKVs) and ellipsoid equation (TKVe). Typical patients were randomly partitioned into development and internal validation sets and subclassified according to height-adjusted TKV (HtTKV) ranges for age (1A-1E, in increasing order). Consortium for Radiologic Imaging Study of PKD (CRISP) participants (n=173) were used for external validation. TKVe correlated strongly with TKVs, without systematic underestimation or overestimation. A longitudinal mixed regression model to predict eGFR decline showed that log2HtTKV and age significantly interacted with time in typical patients, but not in atypical patients. When 1A-1E classifications were used instead of log2HtTKV, eGFR slopes were significantly different among subclasses and, except for 1A, different from those in healthy kidney donors. The equation derived from the development set predicted eGFR in both validation sets. The frequency of ESRD at 10 years increased from subclass 1A(2.4%) to 1E (66.9%) in the Mayo cohort and from 1C (2.2%) to 1E (22.3%) in the younger CRISP cohort. Class and subclass designations were stable. An easily applied classification of ADPKD based on HtTKV and age should optimize patient selection for enrollment into clinical trials and for treatment when one becomes available.

UR - http://www.scopus.com/inward/record.url?scp=84924196321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924196321&partnerID=8YFLogxK

U2 - 10.1681/ASN.2013101138

DO - 10.1681/ASN.2013101138

M3 - Article

C2 - 24904092

AN - SCOPUS:84924196321

VL - 26

SP - 160

EP - 172

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 1

ER -